HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enzyme replacement therapy in fibroblasts from a patient with cholesteryl ester storage disease.

Abstract
Enzyme replacement has long been considered only a remote possibility in the treatment of a wide range of genetic disorders, many manifested as lysosomal storage diseases. The complexity of having a particular enzyme gain access to the lysosomal compartment in a specific cell seemed insurmountable. We report here on an attempt to introduce the enzyme cholesteryl esterase into fibroblasts from a patient with cholesteryl ester storage disease (CESD). The enzyme gains access to the lysosomal compartment and the accumulating cholesteryl ester by virtue of being carried into the cell conjugated to a ligand (insulin or apoprotein B [apoB]) that binds to its own specific receptor and is internalized by the well-described process of receptor-mediated endocytosis. Regardless of whether the enzyme enters the cell via the insulin receptor or via the low-density lipoprotein (ApoB) receptor, it can be found associated with a lysosomal fraction and is effective in lowering levels of accumulated substrate, cholesteryl ester. The time course of the substrate degradation and the dependence on the receptor density and receptor density and receptor-ligand interaction indicate that the enzyme is simply being carried to the site of substrate accumulation by virtue of the fact that that is the destination of the ligand (along with its conjugated enzyme) following internalization.
AuthorsM J Poznansky, S K Hutchison, P J Davis
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 3 Issue 2 Pg. 152-6 (Feb 1989) ISSN: 0892-6638 [Print] United States
PMID2644147 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins B
  • Insulin
  • Receptors, LDL
  • Receptor, Insulin
  • Carboxylic Ester Hydrolases
  • Sterol Esterase
Topics
  • Apolipoproteins B (metabolism)
  • Carboxylic Ester Hydrolases (deficiency)
  • Cholesterol Ester Storage Disease (therapy)
  • Fibroblasts (enzymology)
  • Humans
  • Insulin (metabolism)
  • Lysosomes (enzymology)
  • Receptor, Insulin (metabolism)
  • Receptors, LDL (metabolism)
  • Sterol Esterase (administration & dosage, deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: